CLINICAL_TRIALS
research
· 2010-07-30
Clinical Trial Update: Diffuse Noxious Inhibitory Controls (DNIC): Nociceptive Modulation and Interaction With Neurocognitive Performance in Chronic Pain
Summary
The update describes a study on diffuse noxious inhibitory controls (DNIC) examining nociceptive modulation and its interaction with neurocognitive performance …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Vrije Universiteit Brussel | Conditions: Fibromyalgia, Whiplash | Status: UNKNOWN